GH· Guardant Health Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
GH Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$12.7B
Enterprise value$13.3B
EV / EBITDA (TTM)-32.56
P/E ratio (TTM)—
Forward P/E-147.15
P/S ratio11.75
P/B ratio-125.92
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$188M
Free cash flow (TTM)-$85M
Total cash$1.1B
Total debt$1.7B
Debt / equity—
Current ratio4.68
Income Statement
Total revenue (TTM)$1.1B
Revenue per share (TTM)8.49
Gross profit (TTM)$701M
EBITDA (TTM)-$408M
Net income (TTM)-$433M
EPS diluted (TTM)-3.40
Shares outstanding132,599,929
Float shares127,177,918
Profitability
Gross margin64.90%
Operating margin-40.23%
EBITDA margin-37.79%
Net margin-40.10%
Efficiency
Return on assets (TTM)-17.15%
Return on equity (TTM)—
Price History
Current price$95.70
52 Week high$120.74
52 Week low$36.36
50 day average$88.68
200 day average$84.72
Average volume (10 day)2,064,560
1-year beta1.49
1-year price target$130.10
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:38 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com